Despite New Health Law, Some See Sharp Rise in Premiums Particularly vulnerable to the high rates are small businesses and people who do not have employer-provided insurance and must buy it on their own. In California, Aetna is proposing rate increases of as much as 22 percent, Anthem Blue Cross 26 percent and Blue Shield of California 20 percent for some of those policy holders, according to the insurers’ filings with the state for 2013. These rate requests are all the more striking after a 39 percent rise sought by Anthem Blue Cross in 2010 helped give impetus to the law, known as the Affordable Care Act, which was passed the same year and will not be fully in effect until 2014. In other states, like Florida and Ohio, insurers have been able to raise rates by at least 20 percent for some policy holders.
Corn insecticide linked to great die-off of beneficial honeybees New research has linked springtime die-offs of honeybees critical for pollinating food crops — part of the mysterious malady called colony collapse disorder — with technology for planting corn coated with insecticides. The study, published in ACS' journal Environmental Science & Technology, appears on the eve of spring planting seasons in some parts of Europe where farmers use the technology and widespread deaths of honeybees have occurred in the past. In the study, Andrea Tapparo and colleagues explain that seeds coated with so-called neonicotinoid insecticides went into wide use in Europe in the late 1990s.
Farmers like genetically modified (GM) crops because they can plant them, spray them with herbicide and then there is very little maintenance until harvest. Farmers who plant Monsanto's GM crops probably don't realize what they bargain for when they sign the Monsanto Technology Stewardship Agreement contract. One farmer reportedly 'went crazy' when he discovered the scope of the contract because it transfers ALL liability to the farmer or grower. Here is the paragraph that defines Monsanto's limit of liability that shifts it to the farmer: G. Monsanto Shifts ALL Liability to Farmers
CSPI Says Artificial Caramel Coloring is Quite Different from Real Caramel February 16, 2011 WASHINGTON—The “caramel coloring” used in Coca-Cola, Pepsi, and other foods is contaminated with two cancer-causing chemicals and should be banned, according to a regulatory petition filed today by the Center for Science in the Public Interest. FDA Urged to Prohibit Carcinogenic "Caramel Coloring" ~ Newsroom ~ News from CSPI
I worked for Monsanto and will be releasing documents detailing how Monsanto planned to kill off bee colonies in order to introduce a "new and improved" species of bee that will only pollinate Monsanto crops : politics
Supreme Court: Data Mining Of Prescription Drug Records Is Free Speech
The Drug Market Scam: Why You Pay Way Too Much for Bad Medicine (And Bernie Sanders' Solution) | Drugs June 2, 2011 | Like this article? Join our email list: Stay up to date with the latest headlines via email.
Reporting from Washington — The Food and Drug Administration took the unusual step Wednesday of inviting specialty pharmacies to make an end run around a company that obtained exclusive rights to a pregnancy drug and promptly raised the price from $20 a dose to $1,500. The drug, a synthetic form of progesterone trade-named Makena, is recommended as a weekly injection for women at high risk of delivering prematurely, beginning between 16 and 18 weeks' gestation until 36 weeks. The action by K-V Pharmaceutical Co. boosted the total cost of the drug during a pregnancy from about $400 to $30,000, igniting a firestorm of objections. FDA and Makena: Agency opens up competition for premature pregnancy drug
Antibiotics pipeline ‘drying up,’ WHO warns : epiNewswire By Bryant Furlow on Feb 09, 2011 with Comments 0 The world is in a “race against time” to develop new antibiotics with which to confront a growing tide of multidrug-resistant “super germs” like Acinetobacter baumannii and MRSA, according to a new report in the Bulletin of the World Health Organization. Despite repeated calls for development of new drugs, however, the pharmaceutical industry is largely investing its time and money elsewhere, the Bulletin warns.
A division of the pharmaceutical company Bayer sold millions of dollars of blood-clotting medicine for hemophiliacs -- medicine that carried a high risk of transmitting AIDS -- to Asia and Latin America in the mid-1980's while selling a new, safer product in the West, according to documents obtained by The New York Times. The Bayer unit, Cutter Biological, introduced its safer medicine in late February 1984 as evidence mounted that the earlier version was infecting hemophiliacs with H.I.V. Yet for over a year, the company continued to sell the old medicine overseas, prompting a United States regulator to accuse Cutter of breaking its promise to stop selling the product. 2 Paths of Bayer Drug in 80's: Riskier One Steered Overseas